Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weifuchun in gastric cancer
NCT05888675Phase 1Completed
- Sponsor
- Shuguang Hospital
- Start
- Jul 2016
- Primary completion
- Oct 2020
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of weifuchun in gastric cancer (GC), sponsored by Shuguang Hospital. Started Jul 2016; status: completed.
02
Drugs
weifuchun
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05888675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05888675.